The United States can avoid national security threats by being better prepared for pandemic flu.

AEI's Scott Gottlieb argues that the focus of legislation should not be on creating employment benefits specifically targeted to H1N1, but instead on ways to mitigate risks in future pandemics by providing Americans with early vaccinations.

The development of antivirals for pandemic flu provides important insights into the pharmaceutical industry's ability to advance public health.

We must make a concerted effort today to increase our capacity for timely development of safe, effective and innovative flu vaccines.

We have made progress in pandemic preparedness, but we have a long way to go in ensuring a vibrant and responsive vaccine sector.

The United States' insufficient supply of H1N1 vaccines to inoculate our population demonstrates how poorly prepared we are to confront a pandemic.

The tragedy of AIDS in Africa is that, even absent prosperity, the disease could be controlled--with honesty, integrity and faith in sound science and economic incentives.

We must begin to make our plans more broad-based to encompass the most threatening of pandemic scenarios.